FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

RemedyRepack Pyrazinamide Recall

Pyrazinamide, 500 mg Tablet, packaged in a) 29 x 30-count card

RemedyRepack Inc. · Indiana, PA

Risk level
Class II
Reported by FDA
May 24, 2023
Recall ID
D-0578-2023
Check your lot numberHow we source this data

Summary

RemedyRepack recalled Pyrazinamide starting May 1, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0578-2023 on May 24, 2023. Reason: CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess. Status: Ongoing.

Why it was recalled

CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Product description

Pyrazinamide, 500 mg Tablet, packaged in a) 29 x 30-count card, NDC # 70518-2534-01; b) 1 x 100 UD box, NDC # 70518-2534-00, MFG: Akorn, Lake Forest, IL 60045, Repackaged by : RemedyRepack Inc., PA 15701. Mfg NDC # 61748-0012-01

Lot numbers, UPCs & expiration codes

Lot: a) B2110254-021423, exp. date 08/17/2023; b) J0684183-022323, exp. date 02/28/2024;

Where it was sold

Product was distrituded to three direct account in PA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0578-2023
Classification
Class II
Status
Ongoing
Recall initiated
May 1, 2023
FDA report date
May 24, 2023
Quantity
29 x 30-count card, 1 x 100 UD box
Recall type
Voluntary: Firm initiated
Recalling firm
RemedyRepack Inc.

Original FDA data

Every field from FDA enforcement report D-0578-2023, exactly as published.

Show all FDA fields
City
Indiana
State
PA
Status
Ongoing
Country
United States
Event ID
92239
Address
625 Kolter Dr Ste 4
Code information
Lot: a) B2110254-021423, exp. date 08/17/2023; b) J0684183-022323, exp. date 02/28/2024;
Postal code
15701-3571
Report date
May 24, 2023
Product type
Drugs
Recall number
D-0578-2023
Classification
Class II
Recalling firm
RemedyRepack Inc.
Product quantity
29 x 30-count card, 1 x 100 UD box
Reason for recall
CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Pyrazinamide, 500 mg Tablet, packaged in a) 29 x 30-count card, NDC # 70518-2534-01; b) 1 x 100 UD box, NDC # 70518-2534-00, MFG: Akorn, Lake Forest, IL 60045, Repackaged by : RemedyRepack Inc., PA 15701. Mfg NDC # 61748-0012-01
Distribution pattern
Product was distrituded to three direct account in PA.
Recall initiation date
May 1, 2023
Initial firm notification
Letter
Center classification date
May 16, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0578-2023, published May 24, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls